Skip to content
TriangleGet started
A clearer view of the evidence.
Cancer evidence / Population explorer

Myelodysplastic syndromes (MDS)

All Ages · Both Sexes · All Stages

5-year relative survival

41.8%for this source population

95% confidence interval 41.5%–42.2%

All Ages · Both Sexes · All Stages
Relative survivalYears after diagnosis
Relative survival after diagnosis0%25%50%75%100%0135710
Selected population 5-year: 41.8%

Shading: selected population’s 95% confidence interval. Lines connect published annual estimates.

SEER · 2000-2022 diagnoses
i

A population estimate, not a personal forecast.

Source population: Myelodysplastic syndromes (MDS)Captured September 2026 · Research preview